1.Human Cellular Immune Responses to the Aqueous Fraction of the TSP Antigen of Mycobacterium tuberculosis H37Rv.
Tae Hyun PAIK ; Jeong Kyu PARK ; Hwa Jung KIM ; Eun Kyeong JO ; In Taek HWANG ; Jeong hee KHO ; Jae Hyun LIM ; Dul Lei MIN ; Young Ja SONG
Journal of the Korean Society for Microbiology 1998;33(3):281-294
Phase-partitioning with Triton X-114 (TX114) was applied to the TSP antigen, which may be preferentially associated with the cell wall of M. tuberculosis. The hydrophilic protein components of the TSP antigen were successfully separated from integral hydrophobic macromolecules. To further characterize and examine the cellular immune response of the aqueous fraction of the TSP antigen (TSPa), the in vitro properties of the antigen were measured by lymphoproliferation; surface expression of IL-2 Ra on T lymphocytes was analyzed by flow cytometry; and the cytokine mRNA expression pattern was determined by RT-PCR. Significant lymphoproliferative responses to the TSPa antigen were observed in healthy tuberculin reactive donors after a 5 day in vitro stimulation. TSPa treatment of PBMCs from healthy tuberculin positive subjects for 5 days resulted in progressive augmentation of IFN-r, II 2, and IL-2Ra mRNA expression, as measured by RT-PCR, but considerably reduced IL-4 mRNA expression. In addition, the TSPa antigen stimulated more IL-12 p40 mRNA production than did the PPD antigen, and graduaBy suppressed IL- 10 mRNA expression. Moreover, the CD3' T cells of tuberculin positive subjects displayed a profound increase in their expression of the II 2Ru protein (39.0%) in response to the TSPa antigen. Proliferation was correlated with IL-2 and IL-2Ra mRNAs, but not correlated with distinct IFN-r or IL-12 p40 mRNA production. These findings strongly suggest that the TSPa antigen preferentially evokes the generation of a Thl-like immune response in healthy tuberculin reactors.
Cell Wall
;
Flow Cytometry
;
Humans*
;
Immunity, Cellular*
;
Interleukin-12
;
Interleukin-2
;
Interleukin-4
;
Mycobacterium tuberculosis*
;
Mycobacterium*
;
Neptune
;
RNA, Messenger
;
T-Lymphocytes
;
Tissue Donors
;
Tuberculin
;
Tuberculosis
2.A Case of Huge Calcified Primary Intraventricular Oligdendrogloma.
In Gwan KHO ; Jea Min KIM ; Koang Hum BAK ; Hyung Shik SHIN ; Young Soo KIM ; Yong KO ; Seong Hoon OH ; Suck Jun OH ; Nam Kyu KIM ; Kwang Myung KIM
Journal of Korean Neurosurgical Society 1996;25(1):204-210
Primary intraventricular oligodendroglioma is uncommon and radiological calcification at that location is quite rare. We are reporting a case of huge primary calcified intraventricular oligodendroglioma in the trigone and occipital horn of the left lateral ventricle totally removed through a left parieto-occipital transcortical approach. The clinical, radiological and surgical details of the case are presented with review of literature.
Animals
;
Horns
;
Lateral Ventricles
;
Oligodendroglioma
3.The Results of Antimalarial Treatment of Resurgent Vivax Malaria in Korea.
Chae Seung LIM ; Kyung Ran MA ; Young Kee KIM ; Kap No LEE ; Kwang Hee KIM ; Min Ja KIM ; Won Kyu KHO ; Dae Sung KIM
Korean Journal of Infectious Diseases 1997;29(5):413-416
BACKGROUND: We evaluated the posttreatment response to chloroquine among 81 patients with vivax malaria who were residents in Northern area of Kyunggi province in 1996. The result of chloroquine therapy was followed 28 days after treatment. Material and METHODS: Diagnosis of malaria was made by microscopic examination of Giemsa stain of peripheral blood. Parasitemia levels from each patient were counted before treatment, 3, 14 and 28 days after treatment. RESULTS: Eight-one patients successfully completed the therapy. All patients were army soldiers, who were residing in northern area of Kyunggi province. The 14-day cumulative incidence of therapeutic failure for P. vivax was 2.5% (n=2) and 0% (n=81) at 28th day. One patient had a recurrence eight months after completion of antimalarial treatment. CONCLUSION: The results suggest that recent resurgent malaria in Korea need more careful therapy. Antimalarial treatment should not be completed without microscopic confirmation.
Azure Stains
;
Chloroquine
;
Diagnosis
;
Gyeonggi-do
;
Humans
;
Incidence
;
Korea*
;
Malaria
;
Malaria, Vivax*
;
Military Personnel
;
Parasitemia
;
Plasmodium vivax
;
Primaquine
;
Recurrence
4.Spontaneous Epidural Hematoma of the Lumbo-Sacral Region.
In Gwan KHO ; Nam Kyu KIM ; Kwang Hum BAK ; Hyung Shik SHIN ; Jae Min KIM ; Young Soo KIM ; Yong KO ; Seon Hoon OH ; Suck Jun OH ; Kwang Myung KIM
Journal of Korean Neurosurgical Society 1996;25(2):411-414
Spontaneous epidural hematoma in the spinal canal is an uncommon entity and has usually caused progressive neurological deficits and surgical decompression should be required. A 27-year old patient suffered from acutely developed back pain, associated with a wrenching movement of the back. Several hours later, the symptoms were exaggerated with severely radiating pain to the posterior thigh and calf. The diagnosis was made on CT scan. The patient's clinical manifestations improved completely over a few days with surgical intervention. We reviewed the literatures and discussed the etiological factors of spinal epidural hematoma and the utility of CT scan in differentiating other cause of back pain.
Adult
;
Back Pain
;
Decompression, Surgical
;
Diagnosis
;
Hematoma*
;
Hematoma, Epidural, Spinal
;
Humans
;
Spinal Canal
;
Thigh
;
Tomography, X-Ray Computed
5.Polymorphism of Angiotensin Converting Enzyme in Hypertensive Intracerebral Hemorrhage Patients.
Dong Hwan KIM ; Chul Jin KIM ; Soon Kee KIM ; Jae Woo JHO ; Jung Chung LEE ; Hyoung Ihl KIM ; Kyu Young KHO
Journal of Korean Neurosurgical Society 1998;27(4):425-429
Polymorphism in the angiotensin-converting enzyme(ACE) gene may confer an increased risk of vascular disease. DD type of ACE polymorphism predispose a person to myocardial infarction and IgA nephropathy. The roles of the ACE insertion/deletion polymorphism are unknown in the patients with hypertensive intracerebral hemorrhage (HICH). Our objective is to test and to identify whether genotype distribution of the insertion/deletion polymorphism in ACE gene is different in HICH patients from control subjects. Fifty six HICH patients and sixty one control subjects were studied. Genotypes were determined by the polymerase chain reaction(PCR) with specific oligonucleotide primers flanking the polymorphic region in intron 16 of ACE gene to amplify genomic DNA isolated from patients blood PCR products were separated in 2% agarose gels and bands were visualized by ethidium bromide staining. The PCR reaction amplified a 490bp DNA fragment(II type) from genomic DNA if the subjects had an intact intron 16, and amplified a both 490bp and 190bp DNA fragments(ID type) if subjects had heterozygous polymorphism. While the distribution of ACE polymorphism in control subjects was 26.2%:57.4%:6.4%(II:ID:DD), and the distribution of it in patients with HICH was 37.5%:35.7%:26.8%. Thus, the pattern of distribution was no significant different between control subjects and patients with HICH. The factors of age and sex did not influence on the ratio of distribution in both control and HICH subjects. From these results, we conclude that there is no significant association between I/D polymorphism and HICH.
Angiotensins*
;
DNA
;
DNA Primers
;
Ethidium
;
Gels
;
Genotype
;
Glomerulonephritis, IGA
;
Humans
;
Intracranial Hemorrhage, Hypertensive*
;
Introns
;
Myocardial Infarction
;
Peptidyl-Dipeptidase A*
;
Polymerase Chain Reaction
;
Sepharose
;
Vascular Diseases
6.Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression
Ha Young PARK ; In Jae OH ; Bo Gun KHO ; Tae Ok KIM ; Hong Joon SHIN ; Cheol Kyu PARK ; Yong Soo KWON ; Yu Il KIM ; Sung Chul LIM ; Young Chul KIM ; Yoo Duk CHOI
Tuberculosis and Respiratory Diseases 2019;82(3):227-233
BACKGROUND:
Programmed death-ligand 1 (PD-L1), a transmembrane protein, binds to the programmed death-1 (PD-1) receptor, and anti-PD-1 therapy enables immune responses against tumors. This study aimed to assess clinical characteristics of PD-L1 expression using immunohistochemistry among Korean patients with lung cancer.
METHODS:
We retrospectively reviewed the data of patients with pathologically proven lung cancer from a single institution. PD-L1 expression determined by Tumor Proportion Score (TPS) was detected using 22C3 pharmDx (Agilent Technologies) and SP263 (Ventana Medical Systems) assays.
RESULTS:
From July 2016 to July 2017, 267 patients were enrolled. The main histologic type was adenocarcinoma (69.3%). Most participants were smokers (67.4%) and had clinical stage IV disease (60.7%). In total, 116 (42%) and 58 (21%) patients had TPS ≥1% and ≥50%, respectively. The patients were significantly older in TPS ≥1% group than in TPS <1% group (64.83±9.38 years vs. 61.73±10.78 years, p=0.014), not in TPS ≥50% cutoff value (64.69 ± 9.39 vs. 62.36 ± 10.51, p= 0.178). Regarding histologic grade, higher proportions of poorly differentiated tumor were observed in the TPS ≥1% (40.8% vs. 25.8%, p=0.020) and TPS ≥50% groups (53.2% vs. 27.2%, p=0.004). Among 34 patients examined with 22C3 and SP263 assays, 27 had positive results in both assays, with a cutoff of TPS ≥1% (r=0.826; 95% confidence interval, 0.736–0.916).
CONCLUSION
PD-L1 expression, defined as TPS ??%, was related to older age and poorly differentiated histology. There was a similar distribution of PD-L1 expression in both 22C3 and SP263 results.
7.Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression
Ha Young PARK ; In Jae OH ; Bo Gun KHO ; Tae Ok KIM ; Hong Joon SHIN ; Cheol Kyu PARK ; Yong Soo KWON ; Yu Il KIM ; Sung Chul LIM ; Young Chul KIM ; Yoo Duk CHOI
Tuberculosis and Respiratory Diseases 2019;82(3):227-233
BACKGROUND: Programmed death-ligand 1 (PD-L1), a transmembrane protein, binds to the programmed death-1 (PD-1) receptor, and anti-PD-1 therapy enables immune responses against tumors. This study aimed to assess clinical characteristics of PD-L1 expression using immunohistochemistry among Korean patients with lung cancer. METHODS: We retrospectively reviewed the data of patients with pathologically proven lung cancer from a single institution. PD-L1 expression determined by Tumor Proportion Score (TPS) was detected using 22C3 pharmDx (Agilent Technologies) and SP263 (Ventana Medical Systems) assays. RESULTS: From July 2016 to July 2017, 267 patients were enrolled. The main histologic type was adenocarcinoma (69.3%). Most participants were smokers (67.4%) and had clinical stage IV disease (60.7%). In total, 116 (42%) and 58 (21%) patients had TPS ≥1% and ≥50%, respectively. The patients were significantly older in TPS ≥1% group than in TPS <1% group (64.83±9.38 years vs. 61.73±10.78 years, p=0.014), not in TPS ≥50% cutoff value (64.69 ± 9.39 vs. 62.36 ± 10.51, p= 0.178). Regarding histologic grade, higher proportions of poorly differentiated tumor were observed in the TPS ≥1% (40.8% vs. 25.8%, p=0.020) and TPS ≥50% groups (53.2% vs. 27.2%, p=0.004). Among 34 patients examined with 22C3 and SP263 assays, 27 had positive results in both assays, with a cutoff of TPS ≥1% (r=0.826; 95% confidence interval, 0.736–0.916). CONCLUSION: PD-L1 expression, defined as TPS ??%, was related to older age and poorly differentiated histology. There was a similar distribution of PD-L1 expression in both 22C3 and SP263 results.
Adenocarcinoma
;
Asian Continental Ancestry Group
;
Carcinoma, Non-Small-Cell Lung
;
Gene Expression
;
Humans
;
Immunohistochemistry
;
Lung Neoplasms
;
Lung
;
Retrospective Studies